In this episode of “The Top Line,” we explore the growing space of biopharma prediction markets, how they work and the risks they create around insider information and clinical trial integrity.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
In this episode of “The Top Line,” we explore the growing space of biopharma prediction markets, how they work and the risks they create around insider information and clinical trial integrity.